Relative contributions of b cells and dendritic cells from lupus-Prone mice to CD4 + t cell polarization

Journal of Immunology

Volumn 200, Issue 9, 2018, Pages 3087-3099

  Choi, Seung Chul ^a   Xu, Zhiwei ^a   Li, Wei ^a   Yang, Hong ^a   Roopenian, Derry C ^b   Morse, Herbert C ^c   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; KIDNEY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SLE1 GENE; SPLEEN; STROMA CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TFH CELL; TH1 CELL; TH17 CELL; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL;

EID: 85046260593     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1701179     Document Type: Article

References (64)

1. Mariño, E., and S. T. Grey. 2012. B cells as effectors and regulators of autoimmunity. Autoimmunity 45: 377–387.
2. Vinuesa, C. G., I. Sanz, and M. C. Cook. 2009. Dysregulation of germinal centres in autoimmune disease. Nat. Rev. Immunol. 9: 845–857.
3. Craft, J. E. 2012. Follicular helper T cells in immunity and systemic autoimmunity. Nat. Rev. Rheumatol. 8: 337–347.
4. Blanco, P., H. Ueno, and N. Schmitt. 2016. T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis. Eur. J. Immunol. 46: 281–290.
5. Sozzani, S., A. Del Prete, and D. Bosisio. 2017. Dendritic cell recruitment and activation in autoimmunity. J. Autoimmun. 85: 126–140.
6. Teichmann, L. L., M. L. Ols, M. Kashgarian, B. Reizis, D. H. Kaplan, and M. J. Shlomchik. 2010. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 33: 967–978.
7. Teichmann, L. L., D. Schenten, R. Medzhitov, M. Kashgarian, and M. J. Shlomchik. 2013. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38: 528–540.
8. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417–428.
9. Domeier, P. P., S. B. Chodisetti, C. Soni, S. L. Schell, M. J. Elias, E. B. Wong, T. K. Cooper, D. Kitamura, and Z. S. M. Rahman. 2016. IFN-g receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity. J. Exp. Med. 213: 715–732.
10. Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr. Opin. Immunol. 20: 149–157.
11. Sang, A., Y. Y. Zheng, and L. Morel. 2014. Contributions of B cells to lupus pathogenesis. Mol. Immunol. 62: 329–338.
12. Anolik, J. H. 2013. B cell biology: implications for treatment of systemic lupus erythematosus. Lupus 22: 342–349.
13. Duan, B., and L. Morel. 2006. Role of B-1a cells in autoimmunity. Autoimmun. Rev. 5: 403–408.
14. Griffin, D. O., and T. L. Rothstein. 2011. A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus. J. Exp. Med. 208: 2591–2598.
15. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253–300.
16. Zimecki, M., and J. A. Kapp. 1994. Presentation of antigen by B cell subsets. II. The role of CD5 B cells in the presentation of antigen to antigen-specific T cells. Arch. Immunol. Ther. Exp. 42: 349–353.
17. Margry, B., W. H. Wieland, P. J. van Kooten, W. van Eden, and F. Broere. 2013. Peritoneal cavity B-1a cells promote peripheral CD4+ T-cell activation. Eur. J. Immunol. 43: 2317–2326.
18. Zhong, X., W. Gao, N. Degauque, C. Bai, Y. Lu, J. Kenny, M. Oukka, T. B. Strom, and T. L. Rothstein. 2007. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37: 2400–2404.
19. Wang, Y., and T. L. Rothstein. 2012. Induction of Th17 cell differentiation by B-1 cells. Front. Immunol. 3: 281.
20. Wang, X., K. Ma, M. Chen, K. H. Ko, B. J. Zheng, and L. Lu. 2016. IL-17A promotes pulmonary B-1a cell differentiation via induction of blimp-1 expression during influenza virus infection. PLoS Pathog. 12: e1005367.
21. Morel, L. 2012. Mapping lupus susceptibility genes in the NZM2410 mouse model. Adv. Immunol. 115: 113–139.
22. Mohan, C., Y. Yu, L. Morel, P. Yang, and E. K. Wakeland. 1999. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162: 6492–6502.
23. Chen, Y., C. Cuda, and L. Morel. 2005. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J. Immunol. 174: 7692–7702.
24. Wan, S., C. Xia, and L. Morel. 2007. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J. Immunol. 178: 271–279.
25. Wan, S., Z. Zhou, B. Duan, and L. Morel. 2008. Dendritic cells from lupus prone mice directly interact with B cells to increase their effector functions. Arthritis Rheum. 58: 1741–1750.
26. Sang, A., Y. Y. Zheng, Y. Yin, I. Dozmorov, H. Li, H. C. Hsu, J. D. Mountz, and L. Morel. 2014. Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus. PLoS One 9: e102151.
27. Sobel, E. S., M. Satoh, Y. Chen, E. K. Wakeland, and L. Morel. 2002. The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells. J. Immunol. 169: 2694–2700.
28. Xu, Z., E. J. Butfiloski, E. S. Sobel, and L. Morel. 2004. Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2. J. Immunol. 173: 6050–6058.
29. Morel, L., C. Mohan, Y. Yu, B. P. Croker, N. Tian, A. Deng, and E. K. Wakeland. 1997. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158: 6019–6028.
30. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97: 6670–6675.
31. Sang, A., H. Niu, J. Cullen, S. C. Choi, Y. Y. Zheng, H. Wang, M. J. Shlomchik, and L. Morel. 2014. Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model. J. Immunol. 193: 1609–1621.
32. Marnik, E. A., X. Wang, T. J. Sproule, G. Park, G. J. Christianson, S. K. Lane-Reticker, S. Jain, T. Duffy, H. Wang, G. W. Carter, et al. 2017. Precocious interleukin 21 expression in naive mice identifies a natural helper cell population in autoimmune disease. Cell Reports 21: 208–221.
33. Xu, Z., H. H. Potula, A. Vallurupalli, D. Perry, H. Baker, B. P. Croker, I. Dozmorov, and L. Morel. 2011. Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1. J. Immunol. 186: 6673–6682.
34. Lu, S., L. Zeumer, H. Sorensen, H. Yang, Y. Ng, F. Yu, A. Riva, B. Croker, S. Wallet, and L. Morel. 2015. The murine Pbx1-d lupus susceptibility allele accelerates mesenchymal stem cell differentiation and impairs their immuno-suppressive function. J. Immunol. 194: 43–55.
35. Xu, Z., C. M. Cuda, B. P. Croker, and L. Morel. 2011. The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice. Arthritis Rheum. 63: 764–774.
36. Zhong, X., S. Lau, C. Bai, N. Degauque, N. E. Holodick, S. J. Steven, J. Tumang, W. Gao, and T. L. Rothstein. 2009. A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice. Arthritis Rheum. 60: 3734–3743.
37. Greyner, H. J., T. Wiraszka, L. S. Zhang, W. M. Petroll, and M. E. Mummert. 2010. Inducible macropinocytosis of hyaluronan in B16-F10 melanoma cells. Matrix Biol. 29: 503–510.
38. Sobel, E. S., L. Morel, R. Baert, C. Mohan, J. Schiffenbauer, and E. K. Wakeland. 2002. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J. Immunol. 169: 4025–4032.
39. Xu, Z., B. Duan, B. P. Croker, and L. Morel. 2006. STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. Clin. Immunol. 120: 189–198.
40. Yin, Y., S. C. Choi, Z. Xu, D. J. Perry, H. Seay, B. P. Croker, E. S. Sobel, T. M. Brusko, and L. Morel. 2015. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7: 274ra18.
41. Dienz, O., S. M. Eaton, J. P. Bond, W. Neveu, D. Moquin, R. Noubade, E. M. Briso, C. Charland, W. J. Leonard, G. Ciliberto, et al. 2009. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 206: 69–78.
42. Eddahri, F., S. Denanglaire, F. Bureau, R. Spolski, W. J. Leonard, O. Leo, and F. Andris. 2009. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood 113: 2426–2433.
43. Diehl, S. A., H. Schmidlin, M. Nagasawa, B. Blom, and H. Spits. 2012. IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells. Immunol. Cell Biol. 90: 802–811.
44. Sriram, U., L. Varghese, H. L. Bennett, N. R. Jog, D. K. Shivers, Y. Ning, E. M. Behrens, R. Caricchio, and S. Gallucci. 2012. Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset. J. Immunol. 189: 80–91.
45. Morshed, S. R. M., K. Mannoor, R. C. Halder, H. Kawamura, M. Bannai, H. Sekikawa, H. Watanabe, and T. Abo. 2002. Tissue-specific expansion of NKT and CD5+ B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice. Eur. J. Immunol. 32: 2551–2561.
46. Ishikawa, S., and K. Matsushima. 2007. Aberrant B1 cell trafficking in a murine model for lupus. Front. Biosci. 12: 1790–1803.
47. Mohan, C., L. Morel, P. Yang, and E. K. Wakeland. 1998. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum. 41: 1652–1662.
48. Holodick, N. E., L. Zeumer, T. L. Rothstein, and L. Morel. 2016. Expansion of B-1a cells with germline heavy chain sequence in lupus mice. Front. Immunol. 7: 108.
49. Lee, R. A., C. Mao, H. Vo, W. Gao, and X. Zhong. 2015. Fluorescence tagging and inducible depletion of PD-L2-expressing B-1 B cells in vivo. Ann. N. Y. Acad. Sci. 1362: 77–85.
50. Liu, Z., and A. Davidson. 2012. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat. Med. 18: 871–882.
51. Niu, Y., M. Sengupta, A. A. Titov, S.-C. Choi, and L. Morel. 2017. The PBX1 lupus susceptibility gene regulates CD44 expression. Mol. Immunol. 85: 148–154.
52. Pollard, K. M., D. M. Cauvi, C. B. Toomey, K. V. Morris, and D. H. Kono. 2013. Interferon-g and systemic autoimmunity. Discov. Med. 16: 123–131.
53. Munroe, M. E., R. Lu, Y. D. Zhao, D. A. Fife, J. M. Robertson, J. M. Guthridge, T. B. Niewold, G. C. Tsokos, M. P. Keith, J. B. Harley, and J. A. James. 2016. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann. Rheum. Dis. 75: 2014–2021.
54. Choi, J. Y., J. H. Ho, S. G. Pasoto, V. Bunin, S. T. Kim, S. Carrasco, E. F. Borba, C. R. Gonçalves, P. R. Costa, E. G. Kallas, et al. 2015. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 67: 988–999.
55. Choi, J. Y., A. Seth, M. Kashgarian, S. Terrillon, E. Fung, L. Huang, L. C. Wang, and J. Craft. 2017. Disruption of pathogenic cellular networks by IL-21 blockade leads to disease amelioration in murine lupus. J. Immunol. 198: 2578–2588.
56. Arkatkar, T., S. W. Du, H. M. Jacobs, E. M. Dam, B. Hou, J. H. Buckner, D. J. Rawlings, and S. W. Jackson. 2017. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J. Exp. Med. 214: 3207–3217.
57. Kambayashi, T., and T. M. Laufer. 2014. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat. Rev. Immunol. 14: 719–730.
58. Sobel, E. S., C. Mohan, L. Morel, J. Schiffenbauer, and E. K. Wakeland. 1999. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J. Immunol. 162: 2415–2421.
59. Cuda, C. M., S. Wan, E. S. Sobel, B. P. Croker, and L. Morel. 2007. Murine lupus susceptibility locus Sle1a controls regulatory T cell number and function through multiple mechanisms. J. Immunol. 179: 7439–7447.
60. Perry, D. J., Y. Yin, T. Telarico, H. V. Baker, I. Dozmorov, A. Perl, and L. Morel. 2012. Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor g. J. Immunol. 189: 793–803.
61. Choi, S. C., T. E. Hutchinson, A. A. Titov, H. R. Seay, S. Li, T. M. Brusko, B. P. Croker, S. Salek-Ardakani, and L. Morel. 2016. The lupus susceptibility gene Pbx1 regulates the balance between follicular helper T cell and regulatory T cell differentiation. J. Immunol. 197: 458–469.
62. CrottyS. 2014. T follicular helper cell differentiation, function, and roles in disease. Immunity 41: 529–542.
63. Barr, T. A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37: 3040–3053.
64. Pisetsky, D. S., A. C. Grammer, T. C. Ning, and P. E. Lipsky. 2011. Are autoantibodies the targets of B-cell-directed therapy? Nat. Rev. Rheumatol. 7: 551–556.